Regenxbio (RGNX) EBITDA Margin Growth (3y) (2017 - 2025)
Regenxbio (RGNX) EBITDA Margin Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn | -2,800.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,800.00 |
| Sep 30, 2025 | 9,170.00 |
| Jun 30, 2025 | -10,473.00 |
| Mar 31, 2025 | 33,586.00 |
| Dec 31, 2024 | -32,081.00 |
| Sep 30, 2024 | -7,019.00 |
| Jun 30, 2024 | -1,950.00 |
| Mar 31, 2024 | -18,298.00 |
| Dec 31, 2023 | -3,750.00 |
| Sep 30, 2023 | -23,877.00 |
| Jun 30, 2023 | -11,344.00 |
| Mar 31, 2023 | -13,201.00 |
| Dec 31, 2022 | 15,835.00 |
| Sep 30, 2022 | -2,378.00 |
| Jun 30, 2022 | 27,633.00 |
| Mar 31, 2022 | 373,983.00 |
| Dec 31, 2021 | 7,266.00 |
| Sep 30, 2021 | 24,193.00 |
| Jun 30, 2021 | -25,288.00 |
| Mar 31, 2021 | -31,029.00 |